Royal Bank of Canada
AGN

Royal Bank of Canada’s Allergan plc AGN Stock Holding History

Royal Bank of Canada’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-75,000
Closed -$14.3M – 7250
2019
Q4 		$14.3M Hold
75,000
– – 0.01% 1365
2019
Q3 		$12.6M Sell
75,000
-1,300
-2% -$212K 0.01% 1386
2019
Q2 		$12.8M Buy
76,300
+500
+0.7% +$69.2K 0.01% 1390
2019
Q1 		$11.1M Buy
75,800
+60,800
+405% +$8.81M ﹤0.01% 1455
2018
Q4 		$2M Sell
15,000
-119,500
-89% -$19.6M ﹤0.01% 2638
2018
Q3 		$25.6M Buy
+134,500
New +$24.7M 0.01% 963
2018
Q2 		– Sell
-10,400
Closed -$1.75M – 6930
2018
Q1 		$1.75M Sell
10,400
-7,400
-42% -$1.24M ﹤0.01% 2782
2017
Q4 		$2.91M Buy
17,800
+7,100
+66% +$1.27M ﹤0.01% 2453
2017
Q3 		$2.19M Sell
10,700
-13,000
-55% -$3.02M ﹤0.01% 2594
2017
Q2 		$5.76M Hold
23,700
– – ﹤0.01% 1860
2017
Q1 		$5.66M Buy
23,700
+22,400
+1,723% +$5.22M ﹤0.01% 1827
2016
Q4 		$273K Sell
1,300
-200
-13% -$41.4K ﹤0.01% 4274
2016
Q3 		$345K Sell
1,500
-84,900
-98% -$20.7M ﹤0.01% 4026
2016
Q2 		$20M Buy
86,400
+25,700
+42% +$5.93M 0.01% 965
2016
Q1 		$16.3M Sell
60,700
-331,700
-85% -$95M 0.01% 1061
2015
Q4 		$123M Buy
392,400
+282,600
+257% +$84.1M 0.08% 192
2015
Q3 		$29.8M Buy
109,800
+89,800
+449% +$27.6M 0.02% 559
2015
Q2 		$6.07M Sell
20,000
-56,800
-74% -$16.9M ﹤0.01% 1493
2015
Q1 		$22.9M Buy
76,800
+32,100
+72% +$9.15M 0.02% 748
2014
Q4 		$11.5M Sell
44,700
-26,600
-37% -$6.65M 0.01% 1136
2014
Q3 		$17.2M Buy
71,300
+22,900
+47% +$5.12M 0.01% 893
2014
Q2 		$10.8M Buy
+48,400
New +$10M 0.01% 1182

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Royal Bank of Canada's AGN Position: Q2 2020 in Review

Royal Bank of Canada sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,319,993 shares — an estimated $234M sold.

Royal Bank of Canada first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $505M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Royal Bank of Canada reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 1,319,993 Allergan plc shares in Q2 2020, an estimated $234M.
  • Royal Bank of Canada first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Royal Bank of Canada's Allergan plc position peaked at $505M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.